Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk Women

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-70
SponsorThe Mind Research Network

About this trial

Substance use disorders and psychopathy are serious and costly mental health issues. Psychopathy is known to be associated with aberrant moral decision making and there is considerable interest in determining whether substance use disorders lead to impairments in these same cognitive processes. Recent large-scale research initiatives in forensic settings have begun to identify substance abuse and psychopathy-related disruption in the neural mechanisms involved in moral decision-making processes, and associations between these neural networks and future relapse and antisocial behavior. Here the investigators extend prior work (with incarcerated men) to examine these issues among incarcerated women in order to better understand sex differences. This project addresses the overall lack of neurocognitive research in criminal offenders with substance use disorders, thereby focusing on a major public health issue in an underserved and understudied population.

Eligibility criteria

Qualifiers

Biological sex is female

Intelligence Quotient 70 or higher

Reading level 5th grade or higher

Able to speak and understand English

Disqualifiers

Uncorrectable auditory or visual deficits

Currently pregnant

MRI contraindication

Central nervous system disease

Trial design

Treatments tested in this trial

  • Decision task

Treatment groups

334 Participants
are divided into 7 treatment groups

7

Treatment groups

See each treatment group below.

Sponsors and collaborators